Jonathan C. Fox - 03 Mar 2023 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)

Role
Director
Signature
/s/ John R. Moore, Attorney-in-Fact for Fox Jonathan C
Issuer symbol
EWTX
Transactions as of
03 Mar 2023
Net transactions value
$0
Form type
4
Filing time
07 Mar 2023, 16:59:17 UTC
Previous filing
07 Mar 2023
Next filing
14 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EWTX Stock Option (Right to Buy) Award $0 +43,731 $0.000000 43,731 03 Mar 2023 Common Stock 43,731 $9.43 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/36th of the shares subject to the option vest each month beginning on March 3, 2023, subject to the Reporting Person continuing as a service provider through each vest date.